Medical specialists from Austria tagged as investigators in clinical trials studying Multiple Myeloma
Total 20 results
-
August Zabernigg, Head MD PDSeen in:
- Kufstein, Bezirkskrankenhaus Kufstein, Innere Medizin, Interne II u. onkologische Tagesklinik
Trials:- NCT04891809 (Principal Investigator)
Conditions: -
Bernd Hartmann, MDSeen in:
- Feldkirch, LKH Feldkirch, Innere Medizin II, Interne E: Hämatologie und Onkologie
- Feldkirch, Landeskrankenhaus Feldkirch, Innere Med. II, Interne E
- Rankweil, LKH Feldkirch, Innere Medizin II, Interne E: Hämatologie und Onkologie
- Vorarlberg, Feldkirch, Landeskrankenhaus Feldkirch, Innere Med. II, Interne E
Trials:- NCT04891809 (Principal Investigator)
- NCT04438889 (Principal Investigator)
- NCT06250465 (Principal Investigator)
-
Clemens Schmitt, Prof. MDSeen in:
- Linz, JKU Linz, Univ.-Klinik f. Hämatologie und Internistische Onkologie, MC III.
Trials:- NCT04891809 (Principal Investigator)
Conditions: -
Daniel Lechner-Radner, Senior MDSeen in:
- Vienna, Klinik Hietzing, 5. Medizinische Abteilung
Trials:- NCT04891809 (Principal Investigator)
Conditions: -
Eva M. Autzinger, MDSeen in:
- Vienna, Krankenhaus d. Barmh. Schwestern Wien, 1. Med. Abteilung, Onkologie und Hämatologie
Trials:- NCT04891809 (Principal Investigator)
Conditions: -
Ewald Wöll, Prof. MDSeen in:
- Zams, Krankenhaus Zams, Innere Medizin, Internistische Onkologie-Haematologie
Trials:- NCT04891809 (Principal Investigator)
Conditions: -
Hanns HAUSERSeen in:
- Steyr, LKH Steyr - Investigational Site Number : 0400002
Trials:- NCT04458831 (Principal Investigator)
Conditions: -
Irene StrasslSeen in:
- Linz, Ordensklinikum Linz GmbH Elisabethinen
Trials:- NCT05556616 (Principal Investigator)
Conditions: -
Joachim Rettl, Senior MDSeen in:
- Klagenfurt, Klinik Klagenfurt am Wörthersee Abteilung für Innere Medizin und Hämatologie und internistische Onkologie
Trials:- NCT04891809 (Principal Investigator)
Conditions: -
Klaus Podar, MD, PhDSeen in:
- Mitterweng, Univ.Klinikum Krems, Klin. Abt. f. Innere Medizin 2
Trials:- NCT04891809 (Principal Investigator)
Conditions: -
Maria-Theresa Krauth, Prof.PD MDSeen in:
- Vienna, AKH Meduni Wien Universitätsklinik für Innere Medizin I: Klinische Abteilung für Hämatologie und Hämostaseologie
Trials:- NCT04891809 (Principal Investigator)
Conditions: -
Martin Schreder, MDSeen in:
- Vienna, Klinik Ottakring, 1.Med.Abt., Zentrum f. Onkologie, Haematologie und Palliativmedizin
- Wien, Klinik Ottakring, 1. Med. Abteilung
Trials:- NCT04891809 (Principal Investigator)
- NCT04438889 (Principal Investigator)
Conditions: -
Michael Fillitz, MDSeen in:
- Wien, Hanusch Krankenhaus der Österreichischen Gesundheitskasse, 3. Med. Abteilung
Trials:- NCT04891809 (Principal Investigator)
Conditions: -
Petra PichlerSeen in:
- Saint Poelten, St. Poelten, Universitaetsklinikum St. Poelten
- St. Pölten, Universitätsklinikum St. Pölten, Klinische Abteilung für Innere Medizin 1
- St.Pölten, Univ.-Klinikum St. Pölten, Innere Medizin 1
Trials:- NCT05556616 (Principal Investigator)
- NCT04891809 (Principal Investigator)
- NCT04438889 (Principal Investigator)
- NCT06250465 (Principal Investigator)
-
Richard GreilSeen in:
- Osterreich, Salzburg, Uniklinikum Salzburg
- Other, Salzburg, Salzburg Cancer Research Institute
- Salzburg, Landeskrankenhaus Salzburg
- Salzburg, PMU Salzburg: Universitätsklinik für Innere Medizin III
- Salzburg, Salzburg Cancer Research Institute (SCRI)
- Salzburg, Uniklinikum Salzburg
- Salzburg, Uniklinikum Salzburg, Landeskrankenhaus, Universitatsklinik fur Innere Medizin III der PMU
- Salzburg, Uniklinikum Salzburg, Universitaetsklinik für Innere Medizin III der PMU
- Salzburg, Universitätsklinikum Salzburg
Trials:- NCT04662255 (Principal Investigator)
- NCT04797780 (Principal Investigator)
- NCT04975308 (Principal Investigator)
- NCT04420884 (Principal Investigator)
- NCT05514054 (Principal Investigator)
- NCT05556616 (Principal Investigator)
- NCT05253651 (Principal Investigator)
- NCT04891809 (Principal Investigator)
-
Siegfried Sormann, OA, MDSeen in:
- Graz, Med.Univ.Graz, Univ.-Klinikum f. Innere Medizin, Klin. Abt. f. Haematologie
Trials:- NCT04891809 (Principal Investigator)
Conditions: -
Thamer Sliwa, MD, Head Dept.Seen in:
- Leoben, LKH Hochsteiermark - Leoben, Abt. f. Innere Medizin, Haemato-Onkologie
Trials:- NCT04891809 (Principal Investigator)
Conditions: -
Wolfgang Willenbacher, MD PDSeen in:
- Tirol, Innsbruck, Univ.-Klinik für Innere Medizin V Innsbruck, Abteilung für Hämatologie und Onkologie
Trials:- NCT04891809 (Principal Investigator)
Conditions:
Clinical Trials on Multiple Myeloma
-
Lawson Health Research InstituteThe Ottawa Hospital; Hamilton Health Sciences Corporation; Dalhousie University; Niagara Health SystemActive, not recruitingMultiple Myeloma in Relapse | Multiple Myeloma With Failed Remission | Multiple Myeloma Stage I | Multiple Myeloma Progression | Multiple Myeloma Stage II | Multiple Myeloma Stage IIICanada
-
National Cancer Institute (NCI)Active, not recruitingSmoldering Multiple Myeloma | Refractory Multiple Myeloma | DS Stage I Multiple Myeloma | DS Stage II Multiple Myeloma | DS Stage III Multiple MyelomaUnited States
-
Fred Hutchinson Cancer Research Center/University...National Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
Mayo ClinicCompletedMultiple Myeloma | Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)TerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
City of Hope Medical CenterCompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
University of WashingtonNational Cancer Institute (NCI)TerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States